恆騰網絡(00136.HK):騰訊計算機於中國內地將向集團旗下游戲產品提供技術服務和渠道推廣服務
格隆匯1月10日丨恆騰網絡(00136.HK)公吿,公司附屬公司深圳景秀於2022年1月10日與騰訊計算機訂立持續關連交易協議,其中雙方同意由騰訊計算機於中國內地向集團旗下游戲產品提供技術服務和渠道推廣服務。
目前公司已與騰訊計算機就多款遊戲產品的合作正在洽談之中,其中首款遊戲《傳奇天下》已達成合作。
訂立持續關連交易協議將有助集團拓寬公司的娛樂業務範圍,同時通過影遊聯動,提升公司知識產權的變現能力,並且長遠有利集團充實人才儲備,增強科技實力,幫助公司發展進入新階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.